Abs Direct Equity Fund LLC Legend Biotech Corp Transaction History
Abs Direct Equity Fund LLC
- $74.8 Billion
- Q1 2025
A detailed history of Abs Direct Equity Fund LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Abs Direct Equity Fund LLC holds 33,100 shares of LEGN stock, worth $1.16 Million. This represents 1.5% of its overall portfolio holdings.
Number of Shares
33,100Holding current value
$1.16 Million% of portfolio
1.5%Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
85.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$262 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$238 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$209 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$200 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$200 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.85B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...